TNFSF11 and inflammatory bowel disease: Generally, inflammation and increased pro-inflammatory cytokines (i.e., IL-6, IL-1, IL-17, and TNF-α) affect RANKL production in IBD patients, thereby promoting osteoclastogenesis and bone resorption [28,31].